Skip to main content
Premium Trial:

Request an Annual Quote

CAP Accredits CardioDx's Laboratory

NEW YORK (GenomeWeb News) – CardioDx today said that its laboratory in Palo Alto, Calif., has been accredited by the College of American Pathologists.

The company offers the Corus CAD gene expression test for evaluating patients with signs and symptoms of obstructive coronary artery disease through the laboratory, which is also CLIA certified and licensed by the State of New York.

Late last month, CardioDx announced a deal with Core Diagnostics India to offer Corus CAD in India. Samples will be analyzed at CardioDx's lab.

In addition, the company raised $58 million last summer to support commercialization of the test.

As part of the CAP accreditation process, inspectors examine the laboratory's records, quality control procedures, equipment, facilities, safety program, and overall lab management to ensure they meet CAP requirements.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.